Dural lymphatics regulate clearance of extracellular tau from the CNS.

Mol Neurodegener 2019 02 27;14(1):11. Epub 2019 Feb 27.

Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, MO, 63110, USA.

Background: Alzheimer's disease is characterized by two main neuropathological hallmarks: extracellular plaques of amyloid-β (Aβ) protein and intracellular aggregates of tau protein. Although tau is normally a soluble monomer that bind microtubules, in disease it forms insoluble, hyperphosphorylated aggregates in the cell body. Aside from its role in AD, tau is also involved in several other neurodegenerative disorders collectively called tauopathies, such as progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), some forms of frontotemporal dementia, and argyrophilic grain disease (AGD). The prion hypothesis suggests that after an initial trigger event, misfolded forms of tau are released into the extracellular space, where they spread through different brain regions, enter cells, and seeding previously normal forms. Thus understanding mechanisms regulating the clearance of extracellular tau from the CNS is important. The discovery of a true lymphatic system in the dura and its potential role in mediating Aβ pathology prompted us to investigate its role in regulating extracellular tau clearance.

Methods: To study clearance of extracellular tau from the brain, we conjugated monomeric human tau with a near-infrared dye cypate, and injected this labeled tau in the parenchyma of both wild-type and K14-VEGFR3-Ig transgenic mice, which lack a functional CNS lymphatic system. Following injection we performed longitudinal imaging using fluorescence molecular tomography (FMT) and quantified fluorescence to calculate clearance of tau from the brain. To complement this, we also measured tau clearance to the periphery by measuring plasma tau in both groups of mice.

Results: Our results show that a significantly higher amount of tau is retained in the brains of K14-VEGFR3-Ig vs. wild type mice at 48 and 72 h post-injection and its subsequent clearance to the periphery is delayed. We found that clearance of reference tracer human serum albumin (HSA) was also significantly delayed in the K14-VEGFR3-Ig mice.

Conclusions: The dural lymphatic system appears to play an important role in clearance of extracellular tau, since tau clearance is impaired in the absence of functional lymphatics. Based on our baseline characterization of extracellular tau clearance, future studies are warranted to look at the interaction between tau pathology and efficiency of lymphatic function.

Download full-text PDF

http://dx.doi.org/10.1186/s13024-019-0312-xDOI Listing
February 2019
8 Reads

Publication Analysis

Top Keywords

extracellular tau
clearance extracellular
lymphatic system
tau clearance
tau brain
clearance periphery
tau cns
system dura
dura potential
true lymphatic
potential role
subsequent clearance
periphery delayed
delayed clearance
cns discovery
post-injection subsequent
discovery true


(Supplied by CrossRef)

DM Holtzman et al.
Cold Spring Harb Perspect Med 2012

ES Musiek et al.
Nat Neurosci 2015

EM Mandelkow et al.
Cold Spring Harb Perspect Biol 2012

C Li et al.
Nat Rev Drug Discov 2017

M Jucker et al.
Nature. 2013

AA Davis et al.
Annu Rev Cell Dev Biol 2018

A Calignon de et al.
Neuron. 2012

L Liu et al.
PLoS One 2012

BB Holmes et al.
Proc Natl Acad Sci 2014

N Kfoury et al.
J Biol Chem 2012

B Frost et al.
J Biol Chem 2009

Similar Publications